<?xml version="1.0" encoding="UTF-8"?>
<p>HCV prevalence in all MENA countries ranged very broadly from 0.0% to 100%, with a median of 30.8%. The pooled mean prevalence in all populations with LRDs was 35.5% (95% CI, 31.7%‐39.5%). The pooled mean prevalence was lowest in patients suspected of having an LRD (11.4%; 95% CI, 5.0%‐20.1%) and highest in patients with HCC (56.9%; 95% CI, 50.2%‐63.5%).</p>
